If you have a specific application that requires some modification or customization please call us and let us know your application. This sales literature provides details on our standard Sampling Manifold line. We want to predict what a drug is going to do, and we can get. Boston-based Manifold Bio, a spinoff from George Church ’s lab at Harvard Medical School, is focused on increasing the number of tests that can be performed on protein therapeutics. This system also provides an ideal method to pull batch samples in the final formulation of your product. Manifold Bios platform gives us an unprecedented advantage in our mission to build a pipeline of targeting-enhanced protein therapeutics designed from the. Testing proteins is one way to see how well a drug candidate will work in humans. In the typical cell culture application, using the system provides a simple and easy mechanism for taking daily or periodic samples without breaking into the production line. Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a 40 million Series A financing round led by Triatomic Capital and joined by new investors Section 32, FPV Ventures, Horizons Ventures, and Tencent. The standard 4, 6, 8 or 10 bottle sampling manifolds provide ideal solutions for aseptic sampling, sterile additions, and for pulling samples to be retained. A carrying traydesigned for up to ten 60mL sample bottles and one 500mL purge bottle is included.īio-Simplex Sampling Manifolds Ideal Applications They are sold double bagged and gamma irradiated. All EZ Top®s, tubing and manifolds are made from animal derived component free (ADCF) pharmaceutical grade C-Flex® thermoplastic elastomer (TPE) resin –– engineered to ensure an unobstructed fluid path, a secure elastomeric seal against each bottle with extremely low levels of extractables.īio-Simplex™ Sampling Manifolds are easily used with sterile connecting devices and thermal tubing sealers. Debra Manifold (1961 - 2002) was active/lived in United Kingdom. Transforming drug discovery into measurement-driven drug design A next-generation protein therapeutics company pioneering an in vivo biologics design platform. Each 60mL PETG bottle is connected to the Bio-Simplex™ manifold with 10 inches of tubing with a clamp, an EZ Top® container closure, a 0.2 ?m vent filter and polyethylene cap. Economically designed for the single-use market, Bio-Simplex™ Sampling Manifold Systems are available with either four, six, eight or ten 60mL sampling bottles and an additional 500mL purge bottle at the end of the manifold. Manifold Bio Raises 40 Million Series A to Expand In Vivo Biologics Design Platform BOSTON-(BUSINESS WIRE)-Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a 40 million Series A financing round led by Triatomic Capital and joined by new investors Section 32, FPV Ventures, Horizons Ventures, and Tencent.
0 Comments
Leave a Reply. |